SMTL ID : 3qqu.1 (3 other biounits)

Cocrystal structure of unphosphorylated igf with pyrimidine 8

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

monomer

Ligands

1 x 01P: N~2~-[3-methoxy-4-(morpholin-4-yl)phenyl]-N~4~-(quinolin-3-yl)pyrimidine-2,4-diamine(Non-covalent)

01P.1: 15 residues within 4Å: Chain A: L.20, G.21, Q.22, G.23, V.28, A.46, V.78, E.95, L.96, M.97, D.101, M.157, D.168, M.171, D.174 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.20, A:L.20, A:L.20, A:V.28, A:A.46 Hydrogen bonds: A:M.97, A:M.97, A:D.168

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Buchanan, J.L. et al., Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors. Bioorg.Med.Chem.Lett. (2011)

Release Date

2011-04-20

Peptides

Insulin-like growth factor 1 receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Insulin-like growth factor 1 receptor

Related Entries With Identical Sequence